Skip to content
Search

Latest Stories

Dr Penelope Dash appointed as new chair of NHS England

Health secretary Wes Streeting described Dr Penelope Dash as “a radical reformer” with the skills and experience needed to help fix “the broken” NHS and make it fit for the future.

Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.


Dr Dash is currently the chair of the NHS North West London Integrated Care Board and is leading a major review into the regulation of health and social care quality in England.

Her interim report, published last year, highlighted significant failures at the Care Quality Commission, prompting the appointment of new leadership to turn around the health and care regulator.

With a background as an NHS doctor, a senior partner at McKinsey & Company working on global healthcare, and head of strategy at the Department of Health and Social Care, Dr Dash brings extensive experience across public, private, and government sectors.

As chair of NHS England, she will leverage this expertise to help rebuild the NHS as part of the government’s 10 Year Health Plan.

Confirming her appointment on Monday (3), health secretary Wes Streeting described Dr Dash as “a radical reformer, with the skills and experience we need to help fix our broken NHS and make it fit for the future.”

“I look forward to working with her as we continue to tackle the waiting list backlog, unleash innovation in health services, and support our healthcare staff to deliver the timely care patients deserve,” he added.

Streeting also expressed gratitude to Meddings for his “dedicated service, helping to guide the NHS through the aftermath of the pandemic.”

Dr Dash welcomed the opportunity, stating: “I am excited to start working with my NHS colleagues and the government to accelerate the process of renewal and rebuilding to make sure the NHS continues to serve the needs of its communities and its staff.”

“The 10 Year Health Plan is a once-in-a-generation opportunity to shape the NHS to take on the challenges of the future and I look forward to playing my part,” she added.

Dr Dash was confirmed as the government’s preferred candidate in February. The Secretary of State took the final decision following a hearing with the Health and Social Care Committee on 26 February 2025.

Dr Dash was confirmed as the government’s preferred candidate in February, with the final decision made by the Secretary of State following a hearing with the Health and Social Care Committee on 26 February 2025.

On 28 February, the cross-party Committee chaired by Liberal Democrat MP Layla Moran published a report, setting out its conclusions.

“Dr Dash would be a capable chair and welcomed her focus on data and her commitment to drive best practice across the system to improve the quality of care,” they said.

The Committee recommended that the department appoint a chief executive with a strong track record of delivering change, who can complement Dr Dash’s strong analytical skills.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less